3D bioprinting market
Technology

Global 3D bioprinting market revenue is expected to be contributed majorly by the market in North America

3D bioprinting is a technology that is used for printing of biological tissues and organs through layer-by-layer construction of living cells. These bio-printed products are used for implants or for research purpose.

Major factors driving growth of the global 3D bioprinting market are increasing public and private investments in 3D bioprinting technology for R&D and increasing organ transplantation procedures worldwide. In addition, increasing adoption of 3D bioprinting technology by various sectors such as cosmetic and food is another factor further driving growth of the global market. Major factors restraining growth of the global market are high treatment cost using 3D bioprinting technology, high cost of 3D bioprinting devices, and lack of skilled professionals. In addition, technological advancements in 3D bioprinting technology could provide patient tailored bioactive tissues for craniofacial reconstructions. This factor could create lucrative opportunities for major vendors and healthcare professionals in the global market over the forecast period.

The global 3D bioprinting market is segmented on the basis of technology, applications, and region. Among the technology segments, the syringe-based segment accounts for highest revenue share in the global market.

On the basis of application, the global market is segmented into medical, dental, biosensors, consumer/personal product testing, and food & animal product bioprinting. The medical segment accounts for highest market share in terms of revenue, whereas the dental segment is expected to witness significant growth over the forecast period. The food and animal product bioprinting segment is expected to witness considerable growth during the next 10 years.

Do Inquiry of the Report Here: https://marketresearch.biz/report/3d-bioprinting-market/#inquiry

On the basis of region, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts for highest revenue share in the global 3D bioprinting market; whereas the market in Asia Pacific is expected to witness significant growth over the forecast period.

Key players in the global market are Organovo Holdings Inc., Cyfuse Biomedical K.K., EnvisionTEC GmbH, Allevi, Inc., Nano3D Biosciences Inc., 3Dynamic Systems Ltd., Aspect Biosystems Ltd., Regenovo Biotechnology Co. Ltd., TeVido BioDevices, and Bio3D Technologies.

 

Get Free Sample Copy

captcha

%d bloggers like this: